Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PRESERVE CAP: A Prospective, Multi-Center, Single-Arm, Open-Label Study of Hearts Transplanted After Non-Ischemic Heart Preservation From Extended Donors Continued Access Protocol

NCT06895070 is registered in ClinicalTrials.gov with XVIVO Perfusion as lead sponsor.

NCT NCT06895070
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06895070 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PRESERVE CAP: A Prospective, Multi-Center, Single-Arm, Open-Label Study of Hearts Transplanted After Non-Ischemic Heart Preservation From Extended Donors Continued Access Protocol
Lead sponsor
XVIVO Perfusion
Phase
Not applicable
Overall status
Recruiting
Start date
July 10, 2025
Completion date
May 31, 2031
Enrollment
60 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, heart transplant, transplant; failure, heart